Heterogenic molecular basis for loss of ABLI-BCR transcription: Deletions in der(9)t(9;22) and variants of standard t(9;22) in BCR-ABLI-positive chronic myeloid leukemia

Genes Chromosomes and Cancer

Volumn 34, Issue 2, 2002, Pages 193-200

  Loncarevic, Ivan F ^a,c   Römer, Jennifer ^a   Starke, Heike ^a   Heller, Anita ^a   Bleck, Cordula ^a   Ziegler, Monika ^a   Fiedler, Wolfgang ^a,b   Liehr, Thomas ^a   Clement, Joachim H ^a   Claussen, Uwe ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c Institut fur Humangenetik und Anthropologie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN;

ARTICLE; CHIMERA; CHROMOSOME ABERRATION; CHRONIC MYELOID LEUKEMIA; FUSION GENE; GENE DELETION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; ONCOGENE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; RECIPROCAL CHROMOSOME TRANSLOCATION;

CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 22; CHROMOSOMES, HUMAN, PAIR 9; DNA PROBES; FEMALE; FUSION PROTEINS, BCR-ABL; GENES, ABL; GENETIC HETEROGENEITY; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, MYELOID, CHRONIC; MALE; RNA; TRANSCRIPTION, GENETIC; TRANSLOCATION, GENETIC; VARIATION (GENETICS);

EID: 18444401418     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10056     Document Type: Article

References (29)

1. Clinical, morphological, cytogenetic and molecular aspects of a series of Ph-negative chronic myeloid leukemias
2. A novel BCR-ABL fusion gene (e2/1a) in a patient with Philadelphia-positive chronic myelogenous leukaemia and an aggressive clinical course
3. Sequence and analysis of the human ABL gene, the BCR gene, and regions involved in the Philadelphia chromosomal translocation
4. Subgroup of patients with Philadelphia-positive chronic myelogenous leukemia characterized by a deletion of 9q proximal to ABL gene: Expression profiling, resistance to interferon therapy, and poor prognosis
5. Philadelphia chromosome-negative chronic myeloid leukaemia: A report of 14 new cases
6. Mapping of four distinct BCR-related loci to chromosome region 22q11: Order of BCR loci relative to chronic myelogenous leukemia and acute lymphoblastic leukemia breakpoints
7. Atypical BCR and ABL D-FISH patterns in chronic myeloid leukemia and their possible role in therapy
8. The DNA sequence of human chromosome 22
9. Translocation of BCR to chromosome 9: A new cytogenetic variant detected by FISH in two Ph-negative. BCR-positive patients with chronic myeloid leukemia
10. Localization of the c-ab1 oncogene adjacent to a translocation break point in chronic myelocytic leukaemia
11. RNA for reverse PCR analysis can be obtained from bone marrow cells prepared for cytogenetic analysis and stored at -20 degrees C for several years
12. Reversibility of acute B-cell leukaemia induced by BCR-ABL1
13. Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia
14. The lack of ABL and BCR target sequences on chromosome der(9)t(9;22) in CML is a recurrent anomaly that is detected by fish
15. ABL-BCR mRNAs transcribed from chromosome 9q+ in Philadelphia-chromosomepositive chronic myeloid leukaemia
16. The ABL-BCR fusion gene is expressed in chronic myeloid leukemia
17. Lack of correlation between ABL-BCR expression and response to interferon alpha in chronic myeloid leukaemia
18. Lack of prognostic significance of ABL-BCR mRNA expression in chronic myeloid leukemia patients treated with interferon alpha
19. BCR gene recombines with genomically distinct sites on band 11Q13 in complex BCR-ABL translocations of chronic myeloid leukemia
20. Ph-negative chronic myeloid leukemia: Molecular analysis of ABL insertion into M-BCR on chromosome 22
21. Entire ABL gene is joined with 5′-BCR in some patients with Philadelphia-positive leukemia
22. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining
23. Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia
24. Multiplex reverse transcriptase-polymerase chain reaction screening in childhood acute myeloblastic leukemia
25. Chronic myeloid leukemia from basics to bedside
26. ABL-BCR expression in BCR-ABL-positive human leukemia cell lines
27. Induction of apoprosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR-ABL tyrosine kinase
28. Interferon response in chronic myeloid leukaemia correlates with ABL/BCR expression: A preliminary study